CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net revenue	$ 41,371	$ 33,104
Cost of goods sold	6,791	6,441
Gross profit	34,580	26,663
Operating expenses
Research and development costs	5,773	3,549
Selling, general, and administrative	37,242	23,396
Total operating expenses	43,015	26,945
Operating loss	(8,435)	(282)
Other expense
Other expense	(101)	(27)
Interest expense, net	(668)	(64)
Total other expense	(769)	(91)
Loss before income taxes	(9,204)	(373)
Income tax expense	32	154
Net loss	(9,236)	(527)
Less: cumulative dividends on Series B convertible preferred stock	0	(469)
Net loss attributable to common stockholders	(9,236)	(996)
Foreign currency translation adjustment	(324)	(538)
Comprehensive loss	$ (9,560)	$ (1,534)
Weighted average number of common stocks outstanding:
Basic	76,447,454	46,852,175
Diluted	76,447,454	46,852,175
Net loss per share attributable to common stockholders:
Basic	$ (0.12)	$ (0.02)
Diluted	$ (0.12)	$ (0.02)